Adaptimmune Therapeutics Plc - ADR American Depository Receipt Price (ADAP)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

State of Alaska Department of Revenue Lowers Holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Wed, 22 Mar 2023 07:50:42 UTC via ETF Daily News
: Oncternal Therapeutics stock price target cut to $9 from $14 at OppenheimerWed, 22 Mar 2023 06:13:00 UTC via MarketWatch
Karuna Therapeutics (NASDAQ:KRTX) Shares Gap Up to $191.63Wed, 22 Mar 2023 06:04:41 UTC via ETF Daily News
Assenagon Asset Management S.A. Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Wed, 22 Mar 2023 05:40:46 UTC via ETF Daily News
Entrada Therapeutics (NASDAQ:TRDA) Shares Gap Up to $14.10Wed, 22 Mar 2023 05:32:54 UTC via ETF Daily News
Karuna Therapeutics (NASDAQ:KRTX) Given “Market Outperform” Rating at JMP SecuritiesWed, 22 Mar 2023 04:22:43 UTC via ETF Daily News
Seres Therapeutics (NASDAQ:MCRB) Price Target Increased to $15.00 by Analysts at Canaccord Genuity GroupWed, 22 Mar 2023 04:20:44 UTC via ETF Daily News
Beam Therapeutics (NASDAQ:BEAM) Coverage Initiated by Analysts at Sanford C. BernsteinWed, 22 Mar 2023 04:06:41 UTC via ETF Daily News
BioXcel Therapeutics (NASDAQ:BTAI) Price Target Cut to $66.00 by Analysts at HC WainwrightWed, 22 Mar 2023 03:58:45 UTC via ETF Daily News
CRISPR Therapeutics (NASDAQ:CRSP) Coverage Initiated by Analysts at Sanford C. BernsteinWed, 22 Mar 2023 03:58:41 UTC via ETF Daily News

Adaptimmune Therapeutics Plc - ADR Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ADAP

You don't have any alerts set for IEX:ADAP.

About Adaptimmune Therapeutics Plc - ADR

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

CEOJames J. Noble IndustryBiotechnology SectorHealthcare Websitehttp://www.adaptimmune.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time ADAP to USD Trade Analysis on IEX

Market Status Open

Time Elapsed

Trades Analyzed

Last Price

Trades per Minute

Volume per Trade Average

Volume per Minute Average

Largest Trade Volume

Largest Trade Cost

Total Volume

Total Buy Volume

Total Sell Volume

Buy to Sell Volume

Buy to Sell Trades

USD per Trade Average

USD per Minute Average

USD Total Volume

Buy/Sell stats are based on the side that filled the order.

Real-time Trade History

Waiting for IEX trades to start ...

The last recorded trade was over an hour ago.